David L. Thomas

38.4k citations
320 papers · 31.5k · 9 hit papers · h-index 77

Impact in

  • Hepatology top 0.01%
    • Hepatitis C virus research
    • Liver Disease and Transplantation
  • Epidemiology top 0.02%
    • Hepatitis B Virus Studies
    • Liver Disease Diagnosis and Treatment
    • HIV, Drug Use, Sexual Risk

Papers in

    • Hepatitis C virus research 228
    • Hepatitis Viruses Studies and Epidemiology 13
    • Hepatitis B Virus Studies 128
    • Liver Disease Diagnosis and Treatment 94
    • HIV, Drug Use, Sexual Risk 24

David L. Thomas

314 papers receiving 30.2k citations

David L. Thomas's Hit Papers

Screening and Testing for Hepatitis B Virus Infection: CDC Recommendations — United States, 2023 2023 · 156 citations
1560+8+16Years since publication10002.0k3.0k

Peers

David L. Thomas
Comparison fields: 5 of 170
  • Hepatology 20.1k
  • Epidemiology 16.8k
  • Virology 1.6k
  • Infectious Diseases 3.4k
  • Immunology 2.7k
Replace Gregory J. Dore with:
Gregory J. Dore Australia
Stanislas Pol France
Mark Sulkowski United States
Harvey J. Alter United States
Geoffrey M Dusheiko United Kingdom
Heiner H. Wedemeyer Germany
Graham R. Foster United Kingdom
Jules L. Dienstag United States
Massimo Puoti Italy
Ding‐Shinn Chen Taiwan
David L. Thomas relative to Gregory J. Dore Australia Gregory J. Dore's profile →
Citations per field
00.5×2×2.7×
Gregory J. Dore · 1×
Citations per year

Countries citing papers authored by David L. Thomas

Since Specialization
Citations

This map shows the geographic impact of David L. Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David L. Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David L. Thomas more than expected).

Fields of papers citing papers by David L. Thomas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David L. Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David L. Thomas. The network helps show where David L. Thomas may publish in the future.

Co-authors

The 25 scholars most cited alongside David L. Thomas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David L. Thomas Line = papers co-authored together David L. Thomas links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 320 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection†‡
Hit paper breakdown →
20063959
2
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
Hit paper breakdown →
20082457
3
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
Hit paper breakdown →
20091769
4
Diagnosis, management, and treatment of hepatitis C†
Hit paper breakdown →
20041419
5
HLA and NK Cell Inhibitory Receptor Genes in Resolving Hepatitis C Virus Infection
Hit paper breakdown →
2004981
6
HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS)
Hit paper breakdown →
2002924
7
An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases
Hit paper breakdown →
2011891
8
A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus
Hit paper breakdown →
2013779
9 2002466
10 2002447
11 1999394
12 2002367
13 1995342
14 2003338
15 2003333
16 2005328
17 1998313
18 2006310
19 2009301
20 2007298

About David L. Thomas

David L. Thomas is a scholar working on Hepatology, Epidemiology, Virology, Infectious Diseases and Rheumatology, having authored 320 papers that have together received 31.5k indexed citations. Recurring topics across this work include Hepatitis C virus research (228 papers), Hepatitis B Virus Studies (128 papers), Liver Disease Diagnosis and Treatment (94 papers), HIV, Drug Use, Sexual Risk (24 papers), HIV Research and Treatment (23 papers), HIV/AIDS drug development and treatment (14 papers), Systemic Lupus Erythematosus Research (13 papers) and Hepatitis Viruses Studies and Epidemiology (13 papers). The work is most often cited by research in Hepatology (20.1k citations), Epidemiology (16.8k citations), Virology (1.6k citations), Infectious Diseases (3.4k citations) and Immunology (2.7k citations). David L. Thomas has collaborated with scholars based in United States, India and United Kingdom. Frequent co-authors include Leonard B. Seeff, Doris B. Strader, Mark Sulkowski, Marc G. Ghany, Shruti H. Mehta, David Vlahov, Chloe L. Thio, Michael S Torbenson, Stuart C. Ray and Jacquie A. Astemborski. Their work appears in journals such as Hepatology, Clinical Infectious Diseases, The Journal of Infectious Diseases, Journal of Virology and Journal of Viral Hepatitis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact